Martin Shkreli, Petitioner v. Federal Trade Commission, et al.
Case Number:
23-1338
Court:
Nature of Suit:
-
October 08, 2024
Shkreli Loss, PBM Conspiracy Claims And Ga. Abortion Ban
The U.S. Supreme Court rejected petitions by an Alabama fertility clinic and disgraced pharmaceutical executive Martin Shkreli, among others, in a set of denial orders issued Monday. Meanwhile, in Texas, major drug manufacturers and pharmacy benefit managers have been hit with a suit by the state alleging they conspired to artificially hike the price of insulin medications.
-
October 07, 2024
Justices Won't Hear Shkreli's Bid To Undo $64M Disgorgement
The U.S. Supreme Court refused Monday to review former pharmaceutical executive Martin Shkreli's challenge of a disgorgement order requiring him to pay up to $64 million for an alleged scheme to increase the price of a life-saving drug by 4,000%.
-
August 12, 2024
States Oppose Shkreli High Court Bid For $64M Disgorgement
State enforcers are opposing a petition from ex-pharmaceutical executive Martin Shkreli asking the U.S. Supreme Court to review a disgorgement order requiring him to pay up to $64 million for an alleged scheme to increase the price of a life-saving drug by 4,000%
-
June 28, 2024
Shkreli Asks High Court To Toss $64M Disgorgement Order
Former pharmaceutical executive Martin Shkreli, who gained notoriety for hiking the price of HIV/AIDS medication before serving more than four years in prison for securities fraud, is asking the U.S. Supreme Court to toss a disgorgement order requiring him to pay $64 million for monopolistic price-gouging.